Folgen
Cristina Mitrea
Cristina Mitrea
Lecturer IV, Department of Computational Medicine and Bioinformatics, University of Michigan
Bestätigte E-Mail-Adresse bei umich.edu
Titel
Zitiert von
Zitiert von
Jahr
Methods and approaches in the topology-based analysis of biological pathways
C Mitrea, Z Taghavi, B Bokanizad, S Hanoudi, R Tagett, M Donato, ...
Frontiers in physiology 4, 278, 2013
2522013
A survey of the approaches for identifying differential methylation using bisulfite sequencing data
A Shafi, C Mitrea, T Nguyen, S Draghici
Briefings in bioinformatics 19 (5), 737-753, 2018
802018
Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity
B Bao, C Mitrea, P Wijesinghe, L Marchetti, E Girsch, RL Farr, JL Boerner, ...
Scientific reports 7 (1), 44125, 2017
632017
Network‐based approaches for pathway level analysis
T Nguyen, C Mitrea, S Draghici
Current protocols in bioinformatics 61 (1), 8.25. 1-8.25. 24, 2018
392018
A novel bi-level meta-analysis approach: applied to biological pathway analysis
T Nguyen, R Tagett, M Donato, C Mitrea, S Draghici
Bioinformatics 32 (3), 409-416, 2016
382016
Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion
A Bollig-Fischer, L Marchetti, C Mitrea, J Wu, A Kruger, V Manca, ...
Bioinformatics 30 (21), 3036-3043, 2014
352014
Obesity‐induced MBD 2_v2 expression promotes tumor‐initiating triple‐negative breast cancer stem cells
EA Teslow, C Mitrea, B Bao, RM Mohammad, LA Polin, G Dyson, ...
Molecular oncology 13 (4), 894-908, 2019
302019
DANUBE: data-driven Meta-ANalysis using UnBiased empirical distributions—applied to biological pathway analysis
T Nguyen, C Mitrea, R Tagett, S Draghici
Proceedings of the IEEE 105 (3), 496-515, 2016
302016
Role of TET1 and 5hmC in an obesity-linked pathway driving cancer stem cells in triple-negative breast cancer
B Bao, EA Teslow, C Mitrea, JL Boerner, G Dyson, A Bollig-Fischer
Molecular Cancer Research 18 (12), 1803-1814, 2020
272020
Exogenous IL‐6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild‐type, African American PCa cells
EA Teslow, B Bao, G Dyson, C Legendre, C Mitrea, W Sakr, JD Carpten, ...
Molecular oncology 12 (7), 1138-1152, 2018
232018
Integrating 5hmC and gene expression data to infer regulatory mechanisms
C Mitrea, P Wijesinghe, G Dyson, A Kruger, DM Ruden, S Drăghici, ...
Bioinformatics 34 (9), 1441-1447, 2018
122018
Detecting qualitative changes in biological systems
C Mitrea, A Bollig-Fischer, C Voichiţa, M Donato, R Romero, S Drăghici
Scientific Reports 10 (1), 8146, 2020
42020
Metabolic landscape of the healthy pancreas and pancreatic tumor microenvironment
ME Bonilla, MD Radyk, MD Perricone, AM Elhossiny, AC Harold, ...
JCI insight 9 (18), e180114, 2024
2024
Expression of alternative mRNA splicing variant MBD2_v2 promotes triple-negative breast cancer tumor initiation and is associated with body mass index
EA Teslow, C Mitrea, B Bao, RM Mohammad, LA Polin, G Dyson, ...
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 29 (6), 2020
2020
Abstract B053: Expression of alternative mRNA splicing variant MBD2_v2 promotes triple-negative breast cancer tumor initiation and is associated with body mass index
EA Teslow, C Mitrea, B Bao, RM Mohammad, LA Polin, G Dyson, ...
Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), B053-B053, 2020
2020
SRSF2-dependent MBD2v2 expression is induced by obesity and promotes tumor-initiating triple negative breast cancer stem cells
EA Teslow, C Mitrea, B Bao, RM Mohammad, LA Polin, G Dyson, ...
Cancer Research 79 (13_Supplement), 3680-3680, 2019
2019
Expression Of Obesity Related Genes in Women with Breast Cancer (BC)
S Bandyopadhyay, MHD Daaboul, H Deirawan, N Yerrapotu, I Tsolakian, ...
LABORATORY INVESTIGATION 99, 2019
2019
Obesity enhances tumor colonization and promotes expression of the spliced variant MBD2_v2 and splicing factor SRSF2 in triple-negative breast cancer.
EA Girsch, G Dyson, C Mitrea, B Bao, L Polin, A Bollig-Fischer
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 181-181, 2018
2018
The role of epigenetic reader and alternative mRNA splicing variant MBD2_v2 in IL6 signaling in prostate cancer
E Girsch, B Bao, C Mitrea, WA Sakr, G Dyson, I Powell, A Bollig-Fischer
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 27 (7), 138-138, 2018
2018
Abstract B58: The role of epigenetic reader and alternative mRNA splicing variant MBD2_v2 in IL6 signaling in prostate cancer
E Girsch, B Bao, C Mitrea, WA Sakr, G Dyson, I Powell, A Bollig-Fischer
Cancer Epidemiology, Biomarkers & Prevention 27 (7_Supplement), B58-B58, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20